News

A new, scaffold-free engineered tissue model has been designed to further research into connective tissue disorders.

Scientists at The Wistar Institute have developed a more targeted COVID-19 vaccine that, in animal studies, shows stronger, broader, and more durable protection in a single, low dose.

Scientists have developed a method of producing vital chemical building blocks for use in the pharmaceutical and agrochemical industries.

Researchers have generated a kidney-like 3D tissue from murine stem cells. The structures are composed of three different components and have extensively branched tubules.

A team has found that a compound contained in the medicinal and culinary herb rosemary could be a two-pronged weapon against the SARS-CoV-2 coronavirus that causes COVID-19.

A research team from Scripps Research has been testing an experimental compound called IXA4 in obese mice that might one day be used to prevent or treat Type 2 diabetes. They discovered that the compound activates a signaling pathway that protects the animals from obesity-driven metabolic changes that can lead to diabetes.

Renowned scientists and engineers from the Massachusetts Institute of Technology (MIT) have developed and tested a capsule-based system for oral delivery of mRNA therapeutics.

Researchers have developed a technique to consistently and reproducibly open the blood-brain barrier for the delivery of drugs to the brain.

Researchers have discovered that oligodendrocytes might have a different role in the development of multiple sclerosis than previously thought.

Researchers have discovered where antitumor activity is housed on lankacidin C, a molecule that can be isolated from a common bacterium in soil. They are hoping to use the information to use the molecule as a starting point to engineer anticancer treatments.